• Indaptus Therapeutics Initiates Unrestricted Enrollment of Patients on Decoy20 Weekly Dosing Based on Encouraging Safety Data

    المصدر: Nasdaq GlobeNewswire / 15 أكتوبر 2024 08:00:00   America/New_York

    N/A
شارك على،